“Parlons demain” with Dimitri Labat
Parlons demain is a serie of interviews with Université Paris Cité alumni that enlighten the future.
Dimitri is one of them ! He’s the co-founder of Chipiron. Let’s meet him.
Chipiron has been singled out by Challenges magazine as one of the 100 start-ups to invest in in 2022. Its promise: to make MRI (magnetic resonance imaging) accessible to everyone, everywhere.
Dimitri’s academic background is outstanding. He holds an agrégation in physics, a degree from the Ecole Normale Supérieure and a Phd in condensed matter physics. Dimitry is a true jack-of-all-trades ! He has taught Physics, done fundamental research and worked at the Banque de France where he designed and implemented mathematical models to monitor the activity of insurance companies.
When he created Chipiron, Dimitri wanted to “take research out of the laboratory and make it have a direct impact on people’s lives and on society”. His goal is to democratize MRI and give access to this powerful medical imaging technique to all of those who need it to benefit from the best medical imaging technique available.
À lire aussi
Looking back at The Guild conference: Artificial Intelligence in Higher Education and Research
On November 6th 2024, Université Paris Cité and Université PSL brought together the communities of The Guild of European Research-Intensive Universities for an event about artificial intelligence and its impact on universities, at the PariSanté Campus. Stéphanie...
read more[International Partnership] Major Women’s Health Conference in Singapore
From October 24 to 26, a delegation of fourteen professors, lecturers and researchers from the Faculty of Health, led by Dean Matthieu Resche-Rigon and the co-director of the Institute of Women’s Health, Vassilis Tsatsaris, visited Singapore for the Women’s Health Conference 2024.
read moreInternational Study Characterises for the First Time a New Type of Kidney Transplant Rejection
In cases of kidney failure, transplantation is the treatment of choice. However, the risk of rejection remains high. A better understanding of the immune response to kidney transplant rejection - and in particular the phenomenon of microvascular inflammation - could...
read morePhDs and Companies : Challenges and Opportunities for UPCité Doctoral Students
With 3,050 doctoral students and an ambitious policy for attracting talent, UPCité strives to make its doctoral graduates known and recognised beyond the academic world. Following a recent report published promoting the value of PhDs in businesses, we...
read more